High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
Nobile-Orazio
E
E
Giorgio Spagnol Neuroimmunology Service, Dino Ferrari Centre, Department of Neurological Sciences, Milan University, IRCCS Ospedale Maggiore Policlinico, Via Francesco Sforza 35, I-20122 Milan, Italy.
Bersano
A
A
D004305:Dose-Response Relationship, Drug; D020275:Guillain-Barre Syndrome / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects / Q000379:methods*; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D016472:Motor Neuron Disease / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D010265:Paraproteinemias / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D011129:Polyradiculoneuropathy / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology
D016756:Immunoglobulins, Intravenous